text: The addition of chronic vasodilator therapy with flosequinan to standard digitalis-diuretic regimens is capable of inducing clinical improvement in patients with moderate to severe chronic heart failure .
entities.text: flosequinan
entities.type: intervention
entities.text: patients with moderate to severe chronic heart failure
entities.type: participant